Narcolepsy treatment: pharmacological and behavioral strategies in adults and children

Narcolepsy is a disabling, rare, and chronic sleep disorder, currently classified as distinct central nervous system hypersomnia in narcolepsy type 1 (NT1) and narcolepsy type 2 (NT2). Although today a reliable pathogenic hypothesis identifies the cause of NT1 as an autoimmune process destroying hyp...

Full description

Saved in:
Bibliographic Details
Published in:Sleep & breathing Vol. 24; no. 2; pp. 615 - 627
Main Authors: Franceschini, Christian, Pizza, Fabio, Antelmi, Elena, Folli, Maria Claudia, Plazzi, Giuseppe
Format: Journal Article
Language:English
Published: Cham Springer International Publishing 01.06.2020
Springer Nature B.V
Subjects:
ISSN:1520-9512, 1522-1709, 1522-1709
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Narcolepsy is a disabling, rare, and chronic sleep disorder, currently classified as distinct central nervous system hypersomnia in narcolepsy type 1 (NT1) and narcolepsy type 2 (NT2). Although today a reliable pathogenic hypothesis identifies the cause of NT1 as an autoimmune process destroying hypocretin-producing cells, there is no cure for narcolepsy, and the symptomatic pharmacological available treatments are not entirely effective for all symptoms. Behavioral therapies play a synergistic role in the disease treatment. We here review the available therapeutic options for narcolepsy, including symptomatic pharmacological treatments as well as behavioral and psychosocial interventions that could help clinicians improve the quality of life of patients with narcolepsy in adulthood and childhood.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:1520-9512
1522-1709
1522-1709
DOI:10.1007/s11325-019-01894-4